Page last updated: 2024-12-09
triethyloxonium tetrafluoroborate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
triethyloxonium tetrafluoroborate: a trialkyloxonium salt (Meerweins' reagents) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 2723982 |
| SCHEMBL ID | 26439 |
| MeSH ID | M0046469 |
Synonyms (36)
| Synonym |
|---|
| oxonium, triethyl-, tetrafluoroborate(1-) (1:1) |
| unii-z0b19dd36j |
| oxonium, triethyl-, tetrafluoroborate(1-) |
| einecs 206-705-1 |
| z0b19dd36j , |
| nsc 176023 |
| BB 0262900 |
| AKOS015832945 |
| 368-39-8 |
| triethyloxonium fluoborate |
| boron tetrafluoride triethyl oxonium |
| nsc176023 |
| triethyloxonium tetrafluoroborate(1-) |
| triethoxonium fluoroborate |
| nsc-176023 |
| triethyloxonium fluoroborate |
| triethyloxonium tetrafluoroborate |
| triethyloxonium borofluoride |
| triethyloxonium tetraflouroborate |
| meerwein's reagent |
| T1606 |
| A823393 |
| FT-0602159 |
| meerwein's reagent [mi] |
| triethyloxonium tetrafluoroborate (stablized with 1-3% ether) |
| SCHEMBL26439 |
| triethyloxonium tetra-fluoroborate |
| triethyl oxonium tetrafluoroborate |
| IYDQMLLDOVRSJJ-UHFFFAOYSA-N |
| mfcd00044423 |
| DTXSID20883372 |
| triethyloxonium tetrafluoroborate(15per cent in dichloromethane, ca. 1mol/l) |
| triethyloxidanium;tetrafluoroborate |
| AS-38661 |
| Q7841464 |
| AMY13411 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 33.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (33.74) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||